Scientific Posters

A Randomized, Double-Blind, Placebo-Controlled, Phase 3, Efficacy and Safety Trial of Repinatrabit in Individuals with PKU – Study Design_Otsuka

A Measured Meal Model for Nutrition-Sensitive Trials_Epicured

The Holy Grail of PKU Support – Exploring the Psychosocial Impacts of Camps for Kids with PKU_Ava Henson

Validation of the Executive Function, Attention, and Speed Symptom Inventory for PKU (PKU-EASSI)_Scout Bolton

An App that Combines a Comprehensive Food Database with AI to Simplify Diet Adherence for PKU Families_Cycle

At-Home-Point of Care Urine Test for Blood Phe Monitoring for PKU_Circa

Brain Network Connectivity in Adults with Early-Treated PKU_Lucia Tu

Continuation of Sepiapterin Therapy During Pregnancy in a Patient with PKU_McGrath

How Compliance with Treatment Guidelines Prevents PKU Patients from Accessing New Treatments and Jeopardizes Future Drug Development_Claire Oliver

How Good Is Blood Phe Control in Maternal PKU in Europe – Results from 102 Pregnancies_Pinto

Initial Results from a Coping Skills Intervention for Adolescents with PKU_Markollari

Phase 1 Study of MZE782, an Investigational Oral Medicine for PKU – Safety and Effects on Urinary Phenylalanine_Maze

Point-of-Care Testing for Blood Phe Monitoring_Pinto

Protein and Micronutrient Intake After Two Years of Saproprterin Treatment in PKU_Yilmaz Nas

Real-World Heterogeneity in Sapropterin Administration Among Pediatric and Adult Patients with PKU – Findings from a National Survey_Martina Tosa

Short-Term Tolerability and Acceptability of a Slow-Release Phe-Free Microtablet Protein Substitute in Children and Adolescents with PKU_Martina Tosa

The Invisible Burden of PKU – A Qualitative Exploration of the Experienced Impact of Phenylketonuria Across Borders_Sidra Jendo

Two-Year Outcomes of Sapropterin Treatment in Children with PKU – Longitudinal Observational Study_Ozlem Nas

Considerations for the Use of Pegvaliase in Adolescents with PKU_Erika Vucko